Rapid Increase in the Prevalence of Metronidazole-Resistant Helicobacter pylori in the Netherlands

Emerging Infectious Diseases

Volumn 3, Issue 3, 1997, Pages 385-389

  Van Der Wouden, E J ^a   Van Zwet, A A ^b   Thijs, J C ^a   Vosmaer, G D C ^c   Oom, J A J ^d   De Jong, A ^b   Kleibeuker, J H ^e  

^a Bethesda Hospital   (Netherlands)

^b Public Health Service of Groningen   (Netherlands)

^c Scheper Ziekenhuis   (Netherlands)

^d Diaconessenhuis Meppel   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; METRONIDAZOLE;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; NETHERLANDS; PEPTIC ULCER;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; NETHERLANDS; PEPTIC ULCER;

EID: 0031181679     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0303.970320     Document Type: Article

References (32)

1. Warren JR. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;i:1273.
2. National Institutes of Health. Consensus conference.Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
3. Van der Hulst RWM, Keller JJ, Rauws EAJ, Tytgat GNJ. Treatment of Helicobacter pylori infection: review of the world literature. Helicobacter 1996;1:6-19.
4. Van Zwet AA, Thijs JC, Oom JAJ, Hoogeveen J, Düringshoff BL. Failure to eradicate Helicobacter pylori in patients with metronidazole resistant strains. Eur J Gastroenterol Hepatol 1993;5:185-6.
5. Bell GD, Powell K, Burridge SM, Pallecaros A, Jones PH, Gant PW, et al. Experience with "triple" anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pretreatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther 1992;6:427-35.
6. Rautelin H, Seppäla K, Renkonen OV, Vainio U, Kosunen TU. Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother 1992;36:163-6.
7. Thijs JC, van Zwet AA, Thijs WJ, Van der Wouden EJ, Kooy A. One week triple therapy with omeprazole, amoxicillin, and tinidazole for Helicobacter pylori infection: the significance of imidazole susceptibility. Aliment Pharmacol Ther 1997;11:305-9.
8. Reddy R, Osato M, Gutiérrez O, Kim JG, Graham DY. Metronidazole resistance is high in Korea and Colombia and appears to be rapidly increasing in the U.S [abstract]. Gastroenterology 1996;110:A238.
9. Ling TWK, Cheng AFB, Sung JJY, Yiu PYL, Chung SSC. An increase in Helicobacter pylori strains resistant to metronidazole: a five year study. Helicobacter 1996;1:57-61.
10. Xia HX, Keane CT, O'Morain CA. A 5-year survey of metronidazole and claritromycin resistance in clinical isolates of Helicobacter pylori [abstract]. Gut 1996;39:A6.
11. Lopez-Brea M, Martinez MJ, Domingo D, Sanchez Romero I, Sanz JC, Alarcon T. Evolution of the resistance to several antibiotics in Helicobacter pylori over a four year period [abstract]. Gut 1995;37:A97.
12. Teo EK, Fock KM, Ng TM, Chia SC, Khor CJL, Tan AL, et al. Primary and secondary metronidazole resistant Helicobacter pylori in an urban asian population [abstract]. Gut 1996;39:A23-4.
13. Weissfeld AS, Simmons DE, Vance PH, Trevino E, Kidd S, Greski-Rose P. In vitro susceptibility of pretreatment isolates of Helicobacter pylori from two multicenter United States clinical trials [abstract]. Gastroenterology 1996;110:A295.
14. Van Zwet AA, Thijs JC, Roosendaal R, Kuipers EJ, Pena S, de Graaff J. Practical diagnosis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1996;8:501-7.
15. Berger SA, Gorea A, Moskowitz M, Santo M, Gilat T. Effect of inoculum size on antimicrobial susceptibility of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1993;12:782-3.
16. DeCross AJ, Marshall BJ, McCallum RW, Hoffman SR, Barrett LJ, Guerrant RL. Metronidazole susceptibility testing for H. pylori: comparison of disk, broth and agar dilution methods and their clinical relevance. J Clin Microbiol 1993;31:1971-4.
17. Graham DY, Börsch GM. The who's and when's of therapy for Helicobacter pylori [editorial]. Am J Gastroenterol 1990;85:1552-5.
18. National Committee for Clinical Laboratory Standards. Standard MF-A. Villanova, PA: National Committee for Clinical Laboratory Standards; 1990.
19. Karim QN, Logan RPH. Helicobacter pylori (H. pylori) antimicrobial resistance in the UK [abstract]. Gut 1996;39:A15.
20. De Koster E, Cozzoli A, Jonas C, Ntounda R, Butzler JP, Deltenre M. Six years resistance of Helicobacter pylori to macrolides and imidazoles [abstract]. Gut 1996;39:A5.
21. Thijs JC, Van Zwet AA, Oey HB. Efficacy and side effects of a triple drug regimen for eradication of Helico-bacter pylori. Scand J Gastroenterol 1993;28:934-8.
22. Van Zwet AA, De Boer WA, Schneeberger PM, Weel J, Jansz AR, Thijs JC. Prevalence of primary Helicobacter pylori resistance to metronidazole and claritromycin in The Netherlands. Eur J Clin Microbiol Infect Dis 1996:15:861-4.
23. Ching CK, Leung KP, Yung RWH, Lam SK, Wong BC, Lai KC, Lai CL. Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong. Gut 1996;38:675-8.
24. Banatvala N, Davies GR, Abdi Y, Clements L, Rampton DS, Hardie JM, et al. High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. Gut 1994;35:1562-6.
25. Glupczynski Y, Burette A, De Koster E, Nyst JF, Deltenre M, Cadranel S, et al. Metronidazole resistance in Helicobacter pylori [letter]. Lancet 1990;335:976-7.
26. European Study Group on Antibiotic Susceptibility of Helicobacter pylori. Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1992;11:777-81.
27. Hirschl AM, Hirschl MM, Rotter ML. Comparison of three methods for the determination of the sensitivity of Helicobacter pylori to metronidazole. J Antimicrob Chemother 1993;32:45-9.
28. Midolo PD, Turnidge J, Lambert JR, Bell JM. Validation of a modified Kirby-Bauer disk diffusion method for metronidazole susceptibility testing of Helicobacter Pylori. Diagn Microbial Infect Dis 1995;21:135-40.
29. Becx MCJM, Janssen AJHM, Clasener HAL, de Koning RW. Metronidazole-resistant Helicobacter pylori [letter]. Lancet 1990;335:539-40.
30. Weil J, Bell GD, Powell K, Jobson R, Trowell JE, Gant P, Jones PH. Helicobacter pylori and metronidazole resistance [letter]. Lancet 1990;336:1445.
31. Walt RP. Metronidazole resistant H. pylori - of questionable clinical importance. Lancet 1996;348:489-90.
32. Megraud F. Epidemiology of Helicobacter pylori infection: where are we in 1995? Eur J Gastroenterol Hepatol 1995;7:292-5.